This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Capturing Confectionery (D) (Spanish version)
Collis, David J.; Stuart, Toby; Smith, TroyCase HBS-708S48StrategyIn late 2002, global confectionery and beverage maker Cadbury Schweppes needed to decide whether or not to make an acquisition bid for Adams, an underperforming gum company which had been put up for sale by pharmaceutical giant Pfizer. Examining the decision from a strategic perspective, the (A) case provides brief histories of the two companies; traces the global confectionery industry, focusing especially on chocolate and gum; and details the a...Starting at €5.74
-
Cooper Industries' Corporate Strategy (A) (Spanish version)
Collis, David J.; Stuart, TobyCase HBS-306S08StrategyDescribes the development of a successful corporate strategy based on the acquisition and subsequent consolidation of low-technology manufacturing companies. Starting with a company history and discussion of current business segments, the case goes on to detail the innovation of corporate headquarters in strategy formulation and operations. Highlights the synergistic possibilities in alike acquisitions and addresses the issue of long-term value c...Starting at €8.20
-
Guerra en el sector de la alimentación de animales domésticos (B)
Collis, David J.; Stuart, TobyCase HBS-312S04StrategyDescribe el concurso para la adquisición de Anderson Clayton como actores de la industria compiten por uno de los siete principales fabricantes de alimentos para perros.Starting at €5.74
-
Guerra en el sector de la alimentación de animales domésticos (C)
Collis, David J.; Stuart, TobyCase HBS-312S05StrategyDescribe acontecimientos importantes en la industria de alimentos para mascotas en 1987 y 1988, centrándose en las interacciones competitivas entre los principales actores de la industria.Starting at €5.74
-
Bet on One Big Idea--or Diversify? (HBR Case Study and Commentary)
Stuart, TobyArticle HBS-R1311M-EStrategyA unique probiotic formulation, L-39, has great promise as a pharmaceutical treatment for a common illness. When it hits a stumbling block in its latest clinical trial, Hilde Dach, the scientist leading the research at German drug maker Caliska, faces the prospect that the company may want to reimagine her product as a nutraceutical, because the regulatory hurdles would be easier to clear. Is the company merely hedging its bets to avoid big losse...Starting at €8.20
-
Environmental Platform LEEDership at USGBC
Toffel, Michael W.; Simcoe, Timothy S.; Sesia, AldoCase HBS-618027-EStrategyBy 2018, it was clear that U.S. Green Building Council (USGBC) had significantly contributed to the growth of green building, and over its 25-year history had become a powerful brand in the construction sector with its Leadership in Energy and Environmental Design (LEED) standard. Nonetheless, USGBC faced two significant challenges moving forward: maintaining LEED's leadership position as the green building standard in the U.S., and increasing th...Starting at €8.20
-
BlackRock (C): Integrating BGI
Gulati, Ranjay; Rivkin, Jan W.; Sesia, AldoCase HBS-717406-EStrategyThis (C) case is a supplement to HBS case no. 717-404 "BlackRock (A): Selling the Systems?"Starting at €5.74
-
BlackRock (B): Acquire MLIM - Teaching Note
Gulati, Ranjay; Gilson, Stuart C.; Sesia, AldoTeaching Note HBS-719431-EStrategyTeaching note to case 717405 and 717485Starting at €0.00
-
SmileDirectClub: Better is Better
Schlesinger, Leonard A.; Sesia, AldoCase HBS-320016-EStrategyStarting at €8.20
-
AMC Entertainment: Creating a Spectacular Moviegoing Experience (A), Teaching Plan
McGee, Henry W.; Sesia, AldoTeaching Note HBS-320031-EStrategyTeaching plan for case 319024.Starting at €0.00